Study finds high failure rate in common ABSSSI treatments

11/1/2011 | SkinAndAllergyNews.com

A high failure rate of the 40 most common initial antibiotic therapies for acute bacterial skin and skin structure infections results in longer hospital stays, higher costs and a higher mortality rate, according to a retrospective study presented at the Infectious Diseases Society of America's annual meeting. The study of 3,535 patients found initial treatment failed 22.5% of the time, with vancomycin the most frequently used treatment. Older age, peripheral vascular disease, septicemia/bacteremia, leukopenia, uremia and recent prior hospitalization were risk factors for initial treatment failure, the lead author said.

View Full Article in:

SkinAndAllergyNews.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ